EP3621609
SANFETRINEM EÐA SALT EÐA ESTER ÞEIRRA TIL AÐ NOTA Í MEÐFERÐ VIÐ MÝKÓBAKTERÍU-SÝKINGU
:
EP einkaleyfi í gildi á Íslandi:
4.5.2018:
27.7.2022:
18721053.9
:
30.8.2022:
15.10.2022
:
3.5.2038:
3.5.2026:
31.5.2026
:
SANFETRINEM OR A SALT OR ESTER THEREOF FOR USE IN TREATING MYCOBACTERIAL INFECTION
4.5.2018
27.7.2022
30.8.2022
15.10.2022
3.5.2026
:
GlaxoSmithKline Intellectual Property Development Limited:
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, GB
:
BARROS AGUIRRE, David:
28760 Madrid, ES
:
BATES, Robert H.:
28760 Madrid, ES
:
GONZALEZ DEL RIO, Ruben:
28760 Madrid, ES
:
MENDOZA LOSANA, Alfonso:
28760 Madrid, ES
:
RAMÓN GARCÍA, Santiago:
50008 Zaragoza, ES
:
Zacco Denmark A/S:
Arne Jacobsens Allé 15, DK
:
17382255:
8.5.2017:
EP
:
EP2018061615:
4.5.2018
:
A61K 31/403, A61K 45/06, A61P 31/06, A61P 31/08, A61K 31/133, A61K 31/424, A61K 31/43, A61K 31/454, A61K 31/496
: 6
: 22.4.2023
: 3.5.2024
: Árnason Faktor ehf.
: 7
: 19.4.2024
: 3.5.2025
: Árnason Faktor ehf.
: 8
: 5.5.2025
: 3.5.2026
: Árnason Faktor ehf.